BPA Call HT001421A0031-HT001424F0122
Award Date
9/8/24
Potential Completion Date
9/7/25
Potential Value
$145K
Federal Agency
Defense Health Agency
Awardee
Genomic Health, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Redwood City, CA 94063, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, to provide the Oncotype DX portfolio of genomic cancer testing assays. The $149,624.97 award was issued as a Blanket Purchase Agreement (BPA) call by the Defense Health Agency, with firm fixed pricing. The contract supports the provision of Oncotype Breast Cancer Assay, Oncotype Genomic Prostate Score Assay, and Oncotype Colon Recurrence Score Assay testing services to Department of Defense and...
This federal contract award is for Oncotype DX breast cancer testing services provided by Genomic Health, Inc. to the Defense Health Agency. The $13,815.84 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call, with a performance period ending on May 31, 2018. Genomic Health, a subsidiary of Exact Sciences Corporation, is a for-profit organization that specializes in providing advanced genetic testing services to federal healthcare systems. The company has several large Indefinite...
The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of diagnostic testing supplies for cancer treatment. The potential value of the contract is $150,000.00, with a completion date of September 7, 2022. The contract was not set aside for any specific business type. Genomic Health has a history of providing cancer testing services, including its Oncotype DX portfolio of...
This federal contract award to Genomic Health, Inc. is for the provision of breast cancer testing services to the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense. The $125,000.00 Firm Fixed Price Blanket Purchase Agreement (BPA) contract does not utilize any set-aside designations and was awarded on September 21, 2016, with a completion date of September 20, 2017. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in genomic-based cancer...
The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for cancer testing services. The potential value of the contract is $124,081.53, with a completion date of September 30, 2019. Genomic Health has provided cancer testing services, including its Oncotype DX portfolio of assays, to the Department of Defense and Department of Veterans Affairs under past federal contracts. This award is...
This is a firm fixed-price blanket purchase agreement (BPA) call awarded by the Defense Health Agency to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide Oncotype DX breast cancer testing services. The contract has an ultimate completion date of February 8, 2018 and a ceiling value of $10,361.88. Genomic Health, Inc. is a for-profit organization that specializes in advanced genetic testing services for federal healthcare systems. The company has been awarded several...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, to provide laboratory testing services. The contract has a potential value of $165,621.24 and a period of performance through September 30, 2020. Genomic Health has previously provided cancer testing services, including its Oncotype DX portfolio of assays, to the Department of Defense and Department of Veterans Affairs under over 30...
This award is for a purchase order of $78,364.30 to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide breast cancer testing services to the Defense Health Agency. The contract has a firm fixed price pricing type and a completion date of September 30, 2016. Genomic Health is a for-profit organization that specializes in providing genomic cancer testing services to the federal government, including the Department of Veterans Affairs, Department of Defense, Air Force,...
This is a delivery order awarded to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of Oncotype cancer testing services to the Defense Health Agency (DHA). The contract has a ceiling value of $124,588.79 and a period of performance from March 16, 2025, to March 15, 2026, with the testing to be performed at Nellis Air Force Base in Nevada. The contract is a firm fixed-price type and does not have a set-aside designation. Genomic Health, Inc. is a for-profit...
This contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, is for the provision of Oncotype genetic testing services to the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 22. The $114,305 Blanket Purchase Agreement (BPA) call covers a performance period through February 2026 and allows the VA to order cancer screening, treatment selection, and disease monitoring testing services on an as-needed basis. Genomic Health is also the prime...